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Background: Faced with a life-threatening illness, such as cancer, many patients develop stress symptoms, i.e.
avoidance behaviour, intrusive thoughts and worry. Stress management interventions have proven to be effective;
however, they are mostly performed in group settings and it is commonly breast cancer patients who are studied.
We hereby present the design of a randomized controlled trial (RCT) evaluating the effectiveness and
cost-effectiveness of an individual stress-management intervention with a stepped-care approach in several cancer
diagnoses.
Method: Patients (≥ 18 years) with a recent diagnosis of breast cancer, colorectal cancer, lymphoma, prostate
cancer or testicle cancer and scheduled for adjuvant/curative oncology treatment, will consecutively be included in
the study. In this prospective longitudinal intervention study with a stepped-care approach, patients will be
randomized to control, treatment as usual, or an individual stress-management intervention in two steps. The first
step is a low-intensity stress-management intervention, given to all patients randomized to intervention. Patients
who continue to report stress symptoms after the first step will thereafter be given more intensive treatment at the
second step of the programme. In the intervention patients will also be motivated to be physically active.
Avoidance and intrusion are the primary outcomes. According to the power analyses, 300 patients are planned to
be included in the study and will be followed for two years. Other outcomes are physical activity level, sleep
duration and quality recorded objectively, and anxiety, depression, quality of life, fatigue, stress in daily living, and
patient satisfaction assessed using valid and standardized psychometric tested questionnaires. Utilization of hospital
services will be derived from the computerized patient administration systems used by the hospital. The
cost-effectiveness of the intervention will be evaluated through a cost-utility analysis.
Discussion: This RCT will provide empirical evidence of whether an individually administered stress-management
programme in two steps can decrease stress as well as maintain or enhance patients’ physical activity level, quality
of life and psychological well-being. Further, this RCT, with a stepped-care approach, will provide knowledge
regarding the cost-effectiveness of an individually administered stress-management programme whose aim is to
help and support individual patients at the right level of care.
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Faced with a life-threatening illness, such as cancer, ma-
ny patients develop stress symptoms, i.e. avoidance be-
haviour, intrusive thoughts and worry [1]. These are
all common symptoms of post-traumatic stress disorder
(PTSD), which is defined in the Diagnostic and Sta-
tistical Manual of Mental Disorders - Fourth edition
(DSM-IV) [2] as a phobic and anxious reaction in the
wake of a traumatic experience. Life-threatening illnesses
were included as a potential traumatic event in 1994,
and since then PTSD has been registered as a secondary
diagnosis in many cancer patients [2]. Horowitz and
colleagues [3] define avoidance as a constrict of ideas,
denial of the event (both its meaning and its consequen-
ces) and emotional numbing, while intrusion includes
unbidden thoughts and images, troubled dreams, repeti-
tive behaviour and waves of feelings. PTSD has been
investigated in breast cancer patients [4,5], but little is
known about its prevalence among other cancer diag-
noses [6,7]. A recent study from Sweden reported that,
compared to age-matched controls, men diagnosed with
prostate cancer had an increased risk of psychiatric
treatment for depression, PTSD and use of antidepres-
sants, regardless of risk group and treatment strategy
[8]. In another study, Smith and colleagues [9] con-
cluded that the impact of a cancer diagnosis and treat-
ment persists over the years for many cancer survivors.
Therefore, early identification of those at risk could en-
able treatment to minimize PTSD symptomatology.
Nordin and Glimelius [10] reported that the early iden-
tification of those in need of psychological support at a
later stage of treatment is possible through screening for
clinical levels of worry or depression in combination with
intrusive thoughts in individuals with cancer. Further, it
has been reported [11] that the effects of cancer treatment
on an individual’s quality of life could be predicted using
measures of avoidance behaviour. Impaired general health
as well as deterioration of both physical and social func-
tioning were correlated with extensive avoidance behav-
iour at the start of treatment. Since the research has been
quite static regarding how to properly select, through
screening, the individual patient in order to help and sup-
port him/her at the right level of care, there is a need to
expand the body of knowledge [12,13].
For patients in states of intense stress, the occurrence
of PTSD can be reduced if cognitive behaviour therapy
(CBT) is provided one to three months after a traumatic
event [14]. Also, methods based on CBT have proven to
be able to improve health-related quality of life (HRQoL),
reduce psychosocial stress and increase perceived personal
control of treatment side-effects and disease symptoms in
cancer patients [15,16]. However, at present there is a lack
of solid research findings for comparisons of cost-effect-
iveness and outcome [14].In the “Breast Cancer and Stress” project (BAS project)
[17], the research group wanted to evaluate the effective-
ness and cost-effectiveness of a stress-management inter-
vention for breast cancer patients about to start adjuvant
therapy. Methods based on CBT were used and the inter-
vention was administered in two steps. In the first step,
all participants were offered a low-intensity intervention.
Thereafter, patients were screened regarding clinically re-
levant levels of avoidance, intrusion, anxiety and depres-
sion, and those who reported clinically relevant levels
were offered more intensive treatment in Step 2 of the
programme. Patients who consented to participate in Step
2 were randomized to a more intensive stress-manage-
ment intervention, either in a group setting or indivi-
dually. The hypothesis was that half of the individuals
assigned to a low-intensity intervention would have sig-
nificantly improved after treatment. For individuals who
continue to have symptoms after low-intensity treatment,
it is hypothesized that continued treatment in a group set-
ting with high-intensity interventions will be more cost-
effective than individual treatment.
However, since the BAS project was planned and carried
through, several reports have been published describing
that interventions maintaining or enhancing patients’ phy-
sical activity level were successful in decreasing stress and
increasing quality of life as well as psychological well-
being [18]. Anti-depressant effects have also been reported
to be caused by exercise in self-referred cancer patients
undergoing chemotherapy [19]. Level of physical activity
as well as sleep hours relate to psychological well-being
and quality of life in cancer patients [20]. Therefore, we
wanted to study whether the stress management offered
in the BAS project could be improved using a supplement
whereby the counsellors performing the intervention spe-
cifically worked with motivating the participants to main-
tain or increase their physical activity level during and
after adjuvant/curative treatment. Further, since there is
a lack of knowledge regarding individual stress-manage-
ment interventions in diagnoses other than breast cancer
we decided to include various cancer diagnoses, as well as
both men and women. In addition, since studies reporting
on the cost-effectiveness of stress-management interven-
tions by means of cost-utility analysis (CUA) are scarce,
the interventions in the stepped-care approach will be
evaluated using CUA.
This paper presents the design of a randomized con-
trolled trial evaluating the psychosocial effects and cost-
effectiveness of an individual stress-management inter-
vention, using a stepped-care approach, for patients with
various cancer diagnoses. The intervention is based on
CBT, and includes encouragement to be physically ac-
tive. The hypothesis is that a low-intensity intervention
will be sufficient for half of the individuals to maintain
or improve their psychological well-being after treatment.
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intensity treatment, it is hypothesized that continued
treatment with high-intensity interventions will be more
cost-effective than that of the control group, which entails
treatment as usual.
Specific research questions are:
 Are there any differences between patients who
received an intervention based on CBT and those
who did not, as regards intrusive thoughts,
avoidance behaviour, anxiety, depression, sleep
duration and quality, and/or moderate-vigorous-
intensity physical activity level?
 Is a stress intervention administered at a low or
intensive level a cost-effective way to support
patients with cancer?
 Is it possible to predict at baseline which patients
are in need of a shorter (low level, Step 1) or longer
(intensive level, Step 2) intervention?Method
Patients
Patients (n = 300) over the age of 18 years, with a recent
diagnosis of breast cancer, colorectal cancer, lymphoma,
prostate cancer or testicle cancer and scheduled for ad-
juvant and/or curative treatment in the form of chemo-
therapy, radiation therapy and/or hormonal therapy at the
Department of Oncology and Medical Physics, Haukeland
University Hospital (Department of Oncology), Bergen,
will be consecutively included in the present study. Cri-
teria for exclusion are an ongoing psychiatric condition or
language deficiencies in Norwegian.Design
The study is a prospective, longitudinal intervention stu-
dy with a stepped-care approach whereby patients will
be randomized to individual stress-management inter-
vention (I) or control (C), treatment as usual. A step-
ped-care treatment model seeks to treat patients at the
lowest appropriate level in the first instance, only 'step-
ping up' to intensive/specialist services if clinically re-
quired. One of the key concepts in the stepped-care
model is that treatment methods of varying intensities
are matched to the needs of the individual patient [21].
In Step 1, all patients who are randomized to individual
stress management will be given a low-intensity treat-
ment (I-a). Those patients who do not improve after this
treatment will be given a more intensive treatment (I-b)
in Step 2. This makes the intervention more cost-effect-
ive, since the intensity of the treatment is adjusted to
meet the needs of the individual patient. For a more
detailed overview of the design, see Figure 1.Interventions
In the individual stress-management intervention the
sessions will be 45-60 minutes long, and will take place
at the Department of Oncology or be conducted by tele-
phone if the patient has been discharged from the hos-
pital. If patients live at a great distance from the hospital
some parts of the intervention may be conducted by
telephone, which has been shown to have a similar effect
[22]. The individual stress-management intervention is
planned to be completed within six-months of inclusion.
Step 1 (I-a)
All patients will receive one counselling session when
they start adjuvant/curative therapy at the Department
of Oncology, and a follow-up session face-to-face or over
the telephone. At the first session a thorough evaluation
of the patient’s psychosocial status will be conducted,
according to a model used in a previous study [23]. At
the first session patients will receive written information
about causes and symptoms of stress, self-care measures
to influence stress such as a daily registration of events
and behaviour, scheduled behavioural and physical exer-
cises, along with a short relaxation training. Patients
who do not report clinically significant levels of stress at
the six-week assessment will only participate in these
two sessions. They will, however, be evaluated regularly
for two years (see Figure 1).
Step 2 (I-b)
Patients who report clinically significant levels of stress,
such as intrusive thoughts/avoidance behaviour (mea-
sured using the Impact of Event Scale (IES) [3]) and/or
worry and depression (measured using the Hospital An-
xiety and Depression Scale (HADS) [24]) at the six-week
assessment will be included in Step 2. Step 2 includes
more intensive stress management, with the remaining
four to seven sessions devoted to the themes “What is
stress?”, “What are the symptoms of stress?” and “Irrit-
ability, relationships, the body and pleasure, as well as
an orientation towards the future”. These topics are
based on an earlier intervention [25]. At all sessions the
counsellor will motivate the patient to maintain or in-
crease his or her physical activity level during and after
the cancer treatment. At the final session, the counsellor
will evaluate the patient’s use of the material and ability
to manage his or her stress reactions.
Control group (C)
This condition includes the care offered to all patients,
e.g. all study participants and non-study participants
at the Department of Oncology. It consists of regular
contact with the patient’s own doctor and hospital staff,
as well as the opportunity to take part in the common
Figure 1 The Study design.
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and physical training.
Recruitment
Patients with a previously listed cancer diagnosis will be
invited as soon as a decision has been made to initiate
treatment for cancer. Eligible patients will receive writ-
ten information about the study by post, informing them
that they will be contacted by telephone within a week
by a member of the project staff. During this telephone
call the patients will have the opportunity to ask questionsand receive oral information about the study, before they
decide whether or not they would like to participate.
If they agree to participate they will receive a ques-
tionnaire by post containing a request for a written in-
formed consent and baseline questionnaires. A physical
activity monitor will be mailed to participants when the
baseline questionnaires have been returned (Measure 1).
Thereafter patients will be randomized to one of the two
conditions, intervention or control. In consultation with
each patient who is randomized to the individual stress-
management intervention (I), an appointment for the first
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treatment will be conducted by specially trained staff at
the Department of Oncology, who will schedule appoint-
ments after consultation with the patient. Staff members
conducting the treatment will receive ongoing supervision
throughout the project by a senior researcher.
Data collection
Data will be collected using valid, psychometrically tes-
ted and standardized self-reported questionnaires. Primary
outcome (intrusion and avoidance) will be measured using
the Impact of Event Scale (IES) [3]. Secondary outcomes
regarding psychological well-being will be collected using
the Hospital and Depression Scale (HADS) [24], “Daily
Stress” (VS-20) [26], Short Form Health Survey (SF-36)
[27] and Chalder’s Fatigue Questionnaire (FQ) [28].
Physical activity level as well as sleep duration and
-quality will be recorded using the SenseWear™ Pro3
Armband (Armband (BodyMedia Inc., Pittsburgh, PA,
USA), according to manufacturer instructions, for seven
consecutive days [29]. The SenseWear™ Pro3 Armband is
an activity monitor that is easily applicable, estimates en-
ergy expenditure from five (both physiological and me-
chanical) outputs, and has been found to be valid during
free-living activities [30] as well as in groups of cancer
patients [31].
The generic Euro Quality of Life 5-Dimensional Clas-
sification (EQ-5D) [32] will be used assess health status,
and is suitable for health economic analyses. Data from
medical records will be used to obtain patients’ demo-
graphic and medical background, and information on
the utilization of hospital services will be collected from
the hospitals’ computer systems/medical records. Informa-
tion on the utilization of other professional care facilities
will be collected from patients’ self-reports. Information
regarding sick leave will be collected through self-reports.
Attendance at the individual sessions will be recorded by
the counsellor.
In addition, the intervention as well as the treatment
programmes offered through the regular services of the
Department of Oncology will be evaluated using the
Client Satisfaction Questionnaire (CSQ-8) [33].
All questionnaires will be sent to the patients’ homes
together with a stamped, pre-addressed envelope. Patients
who have not returned the completed questionnaires after
14 days will be contacted by telephone by a member of
the project staff to ensure as high a response rate as
possible.
End-points and statistical analysis
Power calculations have been done for the IES based
on data from another study [23]. On the basis of these
conditions (power = 0.8, p = 0.05 and effect size = 0.59),
at least 128 patients must be included in each group todetect a significant difference on the IES. To account
for the expected dropout and loss of follow-up rates of
15%, we intend to include 300 patients. ANOVA will be
used to analyse differences between groups and for re-
peated measures over time of the continuous variables,
while nominal (categorical) variables will be tested using
chi square (exact). Although all the criteria for normal
distribution are not met with this selection, the paramet-
ric tests are sufficiently robust to be used. Patients’ levels
of stress-related symptoms will be categorized according
to standardized cut-off points. A hierarchical linear re-
gression analysis will be used to examine which variables
predict stress symptoms and the utilization of health
care services, as well as sick leave and return to work.
Net values of the total health care costs will be cal-
culated for the intervention and control groups. Cost–
utility analysis (CUA) using quality adjusted life years
(QALYs) is a general approach in health economic evalu-
ation [34,35]. QALY is an overall measure of health out-
come that weighs a patient’s life expectancy against an
estimate of his or her HRQoL score (measured on a 0–1
scale). Cost-effectiveness ratios (CERs) will be calculated
as (Δ intervention costs + Δ health care costs)/ Δ QALYs
for intervention compared with control. The number of
QALYs gained/lost relative to baseline will be calcu-
lated for each patient assigned to the intervention or
control group as the area under the baseline-adjusted
utility curve.
Ethical considerations
The study has been approved by the Medical Research
Ethics Committee and the Data Inspectorate of Norway
(2010/1911). The intervention in the project will be admi-
nistered by specially trained staff, and will be supervised
continuously so that any potentially harmful effects can be
detected early in treatment and corrected immediately.
Since the design includes a control group who will receive
treatment as usual, it will be possible to monitor patients
for potentially harmful effects. The questionnaires used in
the present study have been chosen with care, in terms of
both length and number. Recording physical activity level
and sleep using an objective monitor as in the present
study has been reported to be feasible and acceptable to
cancer patients, and compliance has been reported as high
[29].
Discussion
By screening for intrusion, avoidance, anxiety and/or de-
pression, the intervention at low- or high-intensity level
will hopefully help and support the individual patients,
both men and women with various cancer diagnoses, at
the right level of care. In the present study, using a
stepped-care approach, it will be possible to evaluate
the effectiveness of both a low-intensity general stress-
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ally tailored stress-management intervention compared
to standard care. Further, we will gain knowledge con-
cerning whether the stress-management intervention
administered here can motivate the participants to main-
tain or increase their physical activity level during and
after adjuvant/curative treatment. Health care and soci-
ety stand to gain substantially from the planned inter-
vention programme, in the form of both individualized
psychosocial support and increased psychological well-
being. This may result in a reduced utilization of health
care, preserved work capacity or a quicker return to
work. The high-intensity individually tailored support
will only be offered to patients who show a clear need,
which may be an economically beneficial model, for both
the patient and society. For research purposes, it is also
important to gain increased knowledge about how to
select and deliver effective supportive intervention for
patients with various psychological needs and cancer
diagnoses. The present study will be integrated within
the usual care at the Department of Oncology. This can
facilitate the implementation of evidenced-based psycho-
social care for cancer patients.
The project has limitations, which should also be no-
ted. Most stress-management interventions have been
delivered in group format. The lack of a third group,
undergoing the stress-management intervention in a
group setting, makes it impossible to compare the effects
of different stress-management intervention settings
(individual vs. group) on stress symptoms compared to a
control group. However, if a third randomization group
had been added to the project it would have prolonged
the time frame by approximately 12 months, which was
not economically justified.
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